Make cell and gene therapy more affordable: PSA tells experts
The govt is also looking at a national mission that drives this affordability.
Talking to experts at the India AMR innovation workshop at CCAMP in Bengaluru, Sood said, "Very often we see cell and gene therapies, which all of you are experts in, and if you look at the cost, that is really something which is not affordable in most countries — even in other developed countries. If you have to really make these therapies accessible, a large effort is needed.
Innovations are taking place in isolated pockets, but the effort has to be amplified.
"
Sood, who also chairs the Prime Minister Science, Technology and Innovation Advisory Council, told TOI: 'Cell and gene therapy was discussed extensively in the recent meeting where we bring out various issues which have to be raised to the level of a mission.
You Can Also Check:
Bengaluru AQI
|
Weather in Bengaluru
|
Bank Holidays in Bengaluru
|
Public Holidays in Bengaluru
We all felt it has to be a multi-ministerial effort, and we will need resources for that — it will be made into a mission — 'a cell and gene therapy mission'.
The idea is how do we really make affordable cell and gene therapy products. While research is going on in a few labs and institutes, lots has to be done to take it to the market.'
He added, 'First, you need the science and technology to make those molecules. After that, it has to be at scale to bring down the cost. One needs a holistic view that they are not only doing it for the country but for the globe. Both things have to go hand in hand.'
'We have to create a way to make our own chemicals. Unless we make that, we cannot reduce the cost. So that has to be, that is what is being done in this, at least in the IIT Bombay, and we will do in the mission,' he said.
He added that therapy like 'ImmunoACT (the CAR-T cell therapy) is heavily supported by govt with initial funding from DBT, ICMR, and DST. How they take it to further reduce the cost is where all the private factors will come in, and they are already coming in.'
Quantum Computing in drug discovery
Meanwhile, Sood also believed that one can't avoid the use of quantum computing in biological sciences — "Billions of dollars are pouring in on drug discovery using quantum computing. That will be a game changer because all those huge permutation combinations will be so trivially done in quantum computing. This is really the future along with materials discovery and so on.'
Antimicrobial resistance
Talking about antimicrobial resistance being a prevalent issue, Ekroop Caur, Secretary, IT, BT, ST department, said, "Even though we may not take antibiotics or we may not misuse antibiotics, we are still affected by it — because what happens in the animal world and plant world will have an impact on us.
This also calls for very strong pharmaceutical regulations, which is part of Karnataka's AMR action plan formulated in 2024."
Taslimarif Saiyed, CEO and Director, CCAMP, pointed out the risk of nearly 10 million people dying annually from AMR — "I don't think one can step back and say we will look at it when it happens. I think collectively all of us are here to say how much I can take down from the 10 million.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
Study estimates 13 per cent of biomedical abstracts published in 2024 involved use of AI
NEW DELHI: At least 13 per cent of research abstracts published in 2024 could have taken help from a large language model, as they included more of 'style' words seen to be favoured by these AI systems, suggests an analysis of more than 15 million biomedical papers published from 2010 to 2024. Powered by artificial intelligence, large language models are trained on vast amounts of text and can, therefore, respond to human requests in the natural language. Researchers from the University of Tübingen, Germany, said the AI models have caused a drastic shift in the vocabulary used in academic writing, with speculation about their influence in scientific writing being common. The study, published in the journal Science, revealed the emergence of large language models has sparked an increase in the usage of certain "stylistic words", including 'delves', 'showcasing', 'underscores', 'potential', 'findings' and 'critical'. The authors explained that the shift in words used during 2023-2024 were not "content-related nouns", rather style-affecting verbs and adjectives that large language models prefer. For the analysis, the researchers used a public health approach, common during the COVID-19 pandemic, for estimating excess deaths. The method involves comparing deaths during the pandemic with those before to assess the impact of COVID-19 on death rates. The approach modified for this analysis was termed as an "excess word" framework by researchers. The findings show an "unprecedented impact" of AI models on scientific writing in biomedical research, "surpassing the effect of major world events such as the COVID-19 pandemic". "We study vocabulary changes in more than 15 million biomedical abstracts from 2010 to 2024 indexed by PubMed and show how the appearance of (large language models) led to an abrupt increase in the frequency of certain style words," the authors wrote.
Time of India
5 hours ago
- Time of India
Call to make cell & gene therapies affordable
Bengaluru: "Innovations in cell and gene therapies are good, but work towards making them affordable," Prof AK Sood, principal scientific advisor (PSA) to the Union govt told researchers Thursday. But what are these therapies that Sood spoke about? They are cutting-edge medical treatments that aim to cure diseases at the source rather than just manage symptoms. Gene therapy fixes faulty genes. And cell therapy uses specially prepared cells - often taken from the patient or a donor - to help the body heal, or fight disease. These are already being used to treat serious conditions like blood cancers and rare genetic diseases. But each treatment can cost lakhs or even crores, making them out of reach for most people. "If we want to make them widely accessible in India, we need a much larger and coordinated effort," Sood told researchers and innovators at India AMR Innovation Workshop held at C-CAMP here. He said the Centre is working on a "Cell and Gene Therapy Mission" that will bring together several ministries and departments. Citing ImmunoACT - a CAR-T cell therapy for cancer treatment that uses the patient's own immune cells to fight the disease - developed with govt support as a good example, he said private companies are now stepping in to take it forward. Pointing out that India lacks strong laws to stop over-the-counter sale of antibiotics, which is a major cause of antimicrobial resistance (AMR) , Sood blamed fake doctors, easy access to antibiotics, and high consultation fees for irresponsible usage. Karnataka IT-BT secretary Ekroop Caur spoke about the rising danger of AMR, saying even people who don't misuse antibiotics can be affected because of what's happening in animals and plants. "That's why Karnataka launched a new AMR action plan this year." C-CAMP CEO and director Taslimarif Saiyed warned AMR could lead to 10 million deaths a year if urgent action isn't taken.
Time of India
a day ago
- Time of India
Make cell & gene therapies affordable, Prof AK Sood, principal scientific advisor (PSA) to Union government told researchers in Bengaluru
Bengaluru: "Innovations in cell and gene therapies are good, but work towards making them affordable," Prof AK Sood, principal scientific advisor (PSA) to the Union govt told researchers Thursday. But what are these therapies that Sood spoke about? They are cutting-edge medical treatments that aim to cure diseases at the source rather than just manage symptoms. Gene therapy fixes faulty genes. It's like correcting the instruction manual in our cells. And cell therapy uses specially prepared cells — often taken from the patient or a donor — to help the body heal, fight disease, or replace damaged cells. You Can Also Check: Bengaluru AQI | Weather in Bengaluru | Bank Holidays in Bengaluru | Public Holidays in Bengaluru These therapies are already being used to treat serious conditions like blood cancers and rare genetic diseases. But each treatment can cost lakhs or even crores of rupees, making them out of reach for most people. "Today, these therapies are extremely expensive — even in developed countries. If we want to make them widely accessible in India, we need a much larger and coordinated effort," Sood told the researchers and innovators at the India AMR Innovation Workshop held at C-CAMP here. He said the Centre is working on a dedicated "Cell and Gene Therapy Mission" that will bring together several ministries and departments. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Villas For Sale in Dubai Might Surprise You Dubai villas | search ads Get Deals Undo "Science and technology is one part. The real challenge is scaling up to reduce costs. We must also develop key chemicals ourselves to cut down on imports," he said, noting that IIT Bombay is already working on this. Citing ImmunoACT — a CAR-T cell therapy for cancer treatment that uses the patient's own immune cells to fight the disease — developed with govt support as a good example, he said private companies are now stepping in to take it forward and reduce costs further. Sood also said quantum computing could speed up the discovery of new drugs by quickly solving complex problems, helping scientists find medicines faster. "This could change the future of healthcare," he said. Pointing out that India lacks strong laws to stop over-the-counter sale of antibiotics, which is a major cause of antimicrobial resistance (AMR), Sood blamed fake doctors, easy access to antibiotics, and high consultation fees for irresponsible usage. Karnataka IT-BT secretary Ekroop Caur spoke about the rising danger of AMR, saying even people who don't misuse antibiotics can be affected because of what's happening in animals and plants. "That's why Karnataka launched a new AMR action plan this year." C-CAMP CEO and director Taslimarif Saiyed warned that AMR could lead to 10 million deaths a year if urgent action isn't taken.
